Pricing Log in Create free account

AEON Biopharma, Inc. (AEON) vs Fractyl Health, Inc. (GUTS)

AEON Biopharma, Inc. and Fractyl Health, Inc. are both Biotechnology companies. Fractyl Health, Inc. is the larger, with a market value of $11.9M against $9.4M — 1.3× the size. Across the 8 metrics below, Fractyl Health, Inc. leads on 6 and AEON Biopharma, Inc. on 2.

Valuation

Metric AEON GUTS Biotechnology median
P/E n/m n/m 10.26
P/S n/m 127.89 9.18
P/B n/m n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.06 0.65
EV/Sales n/m (51.61) 8.98
Earnings yield (2,762.50%) (1,173.80%) (34.89%)
Free cash flow yield (168.78%) (697.71%) (24.52%)

Profitability

Metric AEON GUTS Biotechnology median
Gross margin — 46.24% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 350.00% 1,063.04% (50.12%)
Return on assets (621.70%) (146.75%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AEON GUTS Biotechnology median
Revenue growth (TTM) — (22.50%) 6.26%
EPS growth (last fiscal year) (105.42%) (14.81%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AEON GUTS Biotechnology median
Debt to equity 0.00 (18.29) 0.00
Current ratio 0.54 3.15 4.89
Net debt to EBITDA (2.48) 0.53 1.01

Dividend

Metric AEON GUTS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AEON GUTS Biotechnology median
Market cap 9.35m 11.88m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack